X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9487) 9487
Book Review (1305) 1305
Publication (679) 679
Newsletter (485) 485
Newspaper Article (138) 138
Conference Proceeding (25) 25
Book Chapter (19) 19
Transcript (6) 6
Dissertation (5) 5
Magazine Article (4) 4
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8019) 8019
dexamethasone (5833) 5833
humans (5266) 5266
male (4019) 4019
female (3428) 3428
animals (3167) 3167
oncology (2572) 2572
middle aged (2290) 2290
dexamethasone - administration & dosage (2041) 2041
aged (2028) 2028
hematology (2014) 2014
multiple myeloma (1935) 1935
adult (1861) 1861
dexamethasone - pharmacology (1730) 1730
antineoplastic combined chemotherapy protocols - therapeutic use (1538) 1538
rats (1432) 1432
treatment outcome (1426) 1426
chemotherapy (1385) 1385
multiple myeloma - drug therapy (1361) 1361
pharmacology & pharmacy (1347) 1347
bortezomib (1270) 1270
cancer (1217) 1217
care and treatment (1189) 1189
dexamethasone - therapeutic use (1167) 1167
mice (1152) 1152
therapy (1096) 1096
research (974) 974
steroids (953) 953
analysis (868) 868
antineoplastic combined chemotherapy protocols - adverse effects (812) 812
lenalidomide (750) 750
dose-response relationship, drug (730) 730
stem-cell transplantation (728) 728
corticosteroids (720) 720
medicine & public health (716) 716
aged, 80 and over (715) 715
thalidomide (700) 700
drug therapy (695) 695
survival (656) 656
toxicity (654) 654
dexamethasone - adverse effects (619) 619
transplantation (603) 603
abridged index medicus (598) 598
glucocorticoids (597) 597
dexamethasone - toxicity (589) 589
expression (580) 580
health aspects (556) 556
thalidomide - analogs & derivatives (555) 555
dosage and administration (541) 541
drugs (541) 541
apoptosis (534) 534
inflammation (532) 532
toxicology (528) 528
retrospective studies (527) 527
thalidomide - administration & dosage (524) 524
clinical trials (523) 523
cyclophosphamide (523) 523
antineoplastic agents - therapeutic use (519) 519
antineoplastic combined chemotherapy protocols - administration & dosage (516) 516
disease-free survival (514) 514
drug therapy, combination (500) 500
time factors (495) 495
adolescent (493) 493
cells, cultured (490) 490
recurrence (490) 490
trial (465) 465
cells (464) 464
patients (454) 454
drug administration schedule (453) 453
stem cells (452) 452
immunology (448) 448
combination (445) 445
rats, sprague-dawley (442) 442
antineoplastic agents - adverse effects (429) 429
biochemistry & molecular biology (428) 428
multiple myeloma - therapy (420) 420
survival analysis (418) 418
cyclophosphamide - administration & dosage (417) 417
medical research (415) 415
disease models, animal (412) 412
multiple myeloma - mortality (408) 408
multiple myeloma - pathology (397) 397
article (395) 395
in-vitro (391) 391
prognosis (388) 388
central nervous system depressants (385) 385
doxorubicin - administration & dosage (377) 377
survival rate (375) 375
thalidomide - therapeutic use (373) 373
prospective studies (372) 372
rats, wistar (366) 366
remission induction (365) 365
plus dexamethasone (358) 358
prednisone (358) 358
glucocorticoids - pharmacology (355) 355
cell biology (353) 353
risk factors (353) 353
hematology, oncology and palliative medicine (350) 350
combined modality therapy (349) 349
vincristine - administration & dosage (344) 344
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9940) 9940
Chinese (51) 51
Japanese (30) 30
Spanish (29) 29
French (28) 28
German (21) 21
Russian (9) 9
Czech (7) 7
Polish (7) 7
Italian (6) 6
Korean (6) 6
Portuguese (2) 2
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Haematology, ISSN 0902-4441, 07/2016, Volume 97, Issue 1, pp. 25 - 32
Journal Article
Cancer, ISSN 0008-543X, 02/2006, Volume 106, Issue 4, pp. 848 - 858
BACKGROUND. Pegylated liposomal doxorubicin has pharmacologic and safety advantages over conventional doxorubicin. METHODS. For this noninteriority trial, 192... 
Dexamethasone | Neutropenic fever | Drug toxicity | Multiple myeloma | Liposomes | Drug resistance | Doxorubicin | Pegylated liposomal doxorubicin | Vincristine | Neoplasms | dexamethasone | 1ST-LINE TREATMENT | multiple myeloma | vincristine | ONCOLOGY-GROUP | liposomes | COMBINATION THERAPY | neutropenic fever | CONVENTIONAL DOXORUBICIN | TRANSPLANTATION | pegylated liposomal doxorubicin | THALIDOMIDE PLUS DEXAMETHASONE | KAPOSIS-SARCOMA | ONCOLOGY | drug toxicity | REDUCED-DOSE DEXAMETHASONE | VAD | doxorubicin | drug resistance | neoplasms | DVD-T | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Fever - chemically induced | Multiple Myeloma - drug therapy | Doxorubicin - analogs & derivatives | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Administration, Oral | Catheterization, Central Venous | Treatment Outcome | Polyethylene Glycols - administration & dosage | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Infusions, Intravenous | Doxorubicin - adverse effects | Pharmaceutical research | Drugs | Myelocytic leukemia | Reports | Nonlymphoid leukemia | Research | Drug therapy, Combination | Drug therapy | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1589 - 1596
The Spanish Myeloma Group conducted a trial to compare bortezomib/thalidomide/dexamethasone (VTD) versus thalidomide/dexamethasone (TD) versus vincristine,... 
TRIAL | SURVIVAL | PLUS DEXAMETHASONE | COMPLETE REMISSION | HIGH-DOSE THERAPY | COMPLETE RESPONSE | DOXORUBICIN | PERIPHERAL NEUROPATHY | CONTINUED STANDARD CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Boronic Acids - toxicity | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Dexamethasone - toxicity | Induction Chemotherapy | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Antineoplastic Agents - administration & dosage | Boronic Acids - therapeutic use | Antineoplastic Agents - toxicity | Multiple Myeloma - therapy | Pyrazines - toxicity | Antineoplastic Agents - adverse effects | Female | Boronic Acids - administration & dosage | Thalidomide - adverse effects | Bortezomib | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Thalidomide - administration & dosage | Thalidomide - toxicity | Antineoplastic Combined Chemotherapy Protocols - toxicity | Disease-Free Survival | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Stem Cells - drug effects | Stem Cells - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Thalidomide - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Molecular Human Reproduction, ISSN 1360-9947, 02/2015, Volume 21, Issue 10, pp. 803 - 815
In this study, we aimed to investigate modulation of glucose uptake by the HTR-8/SVneo human first-trimester extravillous trophoblast cell line by a series of... 
Glucose uptake | Proliferation | Xanthohumol | Viability | Trophoblast cells | GLUT1 | proliferation | trophoblast cells | 2-DEOXY-D-GLUCOSE | DEVELOPMENTAL BIOLOGY | viability | OBSTETRICS & GYNECOLOGY | BREAST-CANCER CELLS | HEXOSE TRANSPORTER | QUERCETIN | REPRODUCTIVE BIOLOGY | INHIBITION | glucose uptake | METABOLISM | FETAL | xanthohumol | BINDING | CATECHIN | Deoxyglucose - metabolism | Humans | Propiophenones - pharmacology | Polyphenols - pharmacology | Dexamethasone - toxicity | Stilbenes - pharmacology | Pregnancy Trimester, First | Protein-Tyrosine Kinases - physiology | Trophoblasts - drug effects | Stilbenes - toxicity | Dexamethasone - pharmacology | Phloretin - pharmacology | Female | Polyphenols - toxicity | TOR Serine-Threonine Kinases - physiology | Biological Transport - drug effects | Flavonoids - pharmacology | Propiophenones - toxicity | Trophoblasts - cytology | Phlorhizin - pharmacology | Cytochalasin B - pharmacology | Placentation - drug effects | Phloretin - toxicity | Cytochalasin B - toxicity | Glucose - pharmacology | Cell Division - drug effects | Pregnancy | Cell Movement - drug effects | Flavonoids - toxicity | Melatonin - toxicity | Signal Transduction - drug effects | Glucose Transport Proteins, Facilitative - physiology | Street Drugs - toxicity | Melatonin - pharmacology | Street Drugs - pharmacology | Cell Line, Transformed | Glucose Transport Proteins, Facilitative - antagonists & inhibitors | Phlorhizin - toxicity | Index Medicus
Journal Article
Journal Article
Journal Article